| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/24/2010 | CN101889968A Hair blacking medicine for combing |
| 11/24/2010 | CN101264267B Anti-tumor and anti-cancer medicine and preparation thereof |
| 11/24/2010 | CN101259259B Preparation of Chinese medicinal composition for treating chronic atrophic gastritis |
| 11/24/2010 | CN101244249B Nutrient solution for blackening hair and growing hair, and preparation thereof |
| 11/24/2010 | CN101239158B Chinese medicine for treating appendicitis and preparation thereof |
| 11/24/2010 | CN101239075B Blood platelet aqueous products |
| 11/24/2010 | CN101239074B Application of seal oil in preparing medicaments for treating sexual disorder |
| 11/24/2010 | CN101229183B Ribonucleic acid retrogradation snippet compound and applications thereof |
| 11/24/2010 | CN101199738B Medicament for treating cough and gasp disease |
| 11/24/2010 | CN101181327B Chinese medicine compound preparations for preventing and curing cataptosis and chest bi-syndrome as well as preparation method thereof |
| 11/24/2010 | CN101181305B Extract of acaleph toxin as well as preparation method and usage thereof |
| 11/24/2010 | CN101143890B New born calf brain active peptide, preparation method and application thereof in preparing anti-cancer medicament |
| 11/24/2010 | CN101095752B Chinese traditional medicine for treating burn and scald |
| 11/24/2010 | CN101095729B Medicine for treating lumbar intervertebral disc protrusion |
| 11/23/2010 | US7838727 Derivation of embryonic stem cells |
| 11/23/2010 | US7838637 Single-chain multiple antigen-binding molecule, its preparation and use |
| 11/23/2010 | US7838509 Methods and compositions to improve germ cell and embryo survival and function |
| 11/23/2010 | US7838505 using hybrid Hepatocyte Growth Factor (HGF) construct for prevention and treatment of ischemic and liver disorders |
| 11/23/2010 | US7838292 isolated human olfactory stem cell prepared by culturing human tissue from olfactory neuroepithelium to form neurospheres; treating a neurological disorder such as spinal cord injury, Parkinson's disease, amyotrophic lateral sclerosis and multiple sclerosis |
| 11/23/2010 | US7838291 they produce material which inhibits the proliferation of other, non-entrapped cells, including stem cells and neoplastic and/or hyperproliferative, but otherwise normal cells; cancer; entrapment process can serve as a long-term storage device for maintaining the undifferentiated state of the cells |
| 11/23/2010 | US7838290 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 11/23/2010 | US7838289 Assay utilizing multipotent adult stem cells |
| 11/23/2010 | US7838277 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells |
| 11/23/2010 | US7838210 comprising a motility inhibitor; staining chemically immotile sperm cell suspension with a DNA-selective dye followed by sorting |
| 11/23/2010 | US7838041 autologously transplanting hematopoietic progenitor cell population which has been treated with antibody (monoclonal, chimeric, or humanized; not conjugated to toxin or cytolytic agent); radiotherapy |
| 11/23/2010 | US7838040 Method for regenerating cartilage |
| 11/23/2010 | US7838039 preparing a completely autologous bioadhesive sealant composition; all the blood components come from the patient to whom the sealant will be used |
| 11/23/2010 | US7838038 Biomaterial and preparation method thereof |
| 11/23/2010 | US7838022 Bioresorbable solids admixed with a liquid carrier to form shape-retaining putties, flowable pastes, or particulated sponges; solid is a crosslinked collagen and particulate DBM; liquid is an aqueous polysaccharide; injectable; improved ease of handling by surgeons |
| 11/23/2010 | US7838006 Viral vaccine composition, process and methods of use |
| 11/23/2010 | US7837995 Anticancer agents; low dosage; side effect reduction |
| 11/23/2010 | US7837990 In vivo expanded NKT cells and methods of use thereof |
| 11/23/2010 | US7837989 Method for preventing or treating the development of respiratory allergies |
| 11/23/2010 | US7837884 Methods and apparatus for isolating platelets from blood |
| 11/23/2010 | US7837708 Placing a length of suture into a sterile container;obtaining an autogenous blood component by centrifuging the patient's blood,dding an anticoagulant to keep the blood component in suspension and then adding to the container where the suture soaks up the autogenous blood component; surgery |
| 11/23/2010 | CA2461068C Cell populations which co-express cd49c and cd90 |
| 11/23/2010 | CA2425025C Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 11/23/2010 | CA2373302C Conditioned cell culture medium compositions and methods of use |
| 11/23/2010 | CA2222140C Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 11/23/2010 | CA2209301C Redirection of cellular immunity by protein-tyrosine kinase chimeras |
| 11/23/2010 | CA2169292C Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 11/18/2010 | WO2010132764A2 Live-attenuated compositions for bacterial infections |
| 11/18/2010 | WO2010132315A1 Enhanced hematopoietic stem cell engraftment |
| 11/18/2010 | WO2010132017A1 Probiotic juice drink |
| 11/18/2010 | WO2010131917A2 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof |
| 11/18/2010 | WO2010131718A1 Anti-hyperglycemic and/or anti-hyperlipidemic agent comprising material containing avian skin-derived sphingomyelin as active ingredient |
| 11/18/2010 | WO2010130980A2 Treatment of stress |
| 11/18/2010 | WO2010130785A2 Novel use of probiotics |
| 11/18/2010 | WO2010130713A1 Specialized medical nutrition for surgical and trauma patients containing probiotics |
| 11/18/2010 | WO2010130710A1 Complete liquid nutrition for children at the age of 1-10 years comprising probiotics |
| 11/18/2010 | WO2010130704A1 Oral nutritional supplement comprising probiotics |
| 11/18/2010 | WO2010130702A1 Infant and young children feeding formula comprising probiotics for infants and young children |
| 11/18/2010 | WO2010130701A1 Specialized nutritional formula for adult patients with gastrointestinal intolerance containing probiotics |
| 11/18/2010 | WO2010130700A1 Nutritionally balanced standard tube feeding formula containing probiotics |
| 11/18/2010 | WO2010130699A1 Probiotic containing modules for tube feeding |
| 11/18/2010 | WO2010130697A1 Oral nutritional supplement for children comprising probiotics |
| 11/18/2010 | WO2010130663A1 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders |
| 11/18/2010 | WO2010130662A1 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS |
| 11/18/2010 | WO2010130661A1 Prevention and treatment of allergic diarrhoea |
| 11/18/2010 | WO2010130660A1 Non-replicating micro-organisms and their immune boosting effect |
| 11/18/2010 | WO2010130659A1 Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles |
| 11/18/2010 | WO2010130069A1 Use of pharmaceutical composition for preparing medicine for treating autoimmune disease |
| 11/18/2010 | WO2010099617A8 Symbiotic maple product compositions and methods |
| 11/18/2010 | WO2010081012A3 Disease control with tick phospholipase a2 |
| 11/18/2010 | WO2010033426A3 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
| 11/18/2010 | US20100293624 Elimination of n-glucolylneuraminic acid from animal products for human use |
| 11/18/2010 | US20100292791 Fully synthetic implantable multi-phased scaffold |
| 11/18/2010 | US20100292734 Multi-layer osteoinductive, osteogenic, and osteoconductive carrier |
| 11/18/2010 | US20100291678 Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses |
| 11/18/2010 | US20100291251 Method for production of carotenoid |
| 11/18/2010 | US20100291227 Lip lubricant and method of lubricating the lips |
| 11/18/2010 | US20100291226 Pharmaceutical Formulations Based on Apolar and Polar Lipids for Ophthalmic Use |
| 11/18/2010 | US20100291223 Treatment for dermatological conditions |
| 11/18/2010 | US20100291219 Methods and compositions relating to progenitor cells |
| 11/18/2010 | US20100291211 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue |
| 11/18/2010 | US20100291192 Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria |
| 11/18/2010 | US20100291188 Periostin Inhibitory Compositions for Myocardial Regeneration, Methods of Delivery, and Methods of Using Same |
| 11/18/2010 | US20100291176 Manufacturing three-dimensional scaffolds using cryogenic prototyping |
| 11/18/2010 | US20100291171 Hyaluronic acid derivatives obtained via "click chemistry" crosslinking |
| 11/18/2010 | US20100291153 Vaccines against bordetella pertussis based on lps glycosyltransferase mutants |
| 11/18/2010 | US20100291139 Recombinant mva virus and the use thereof |
| 11/18/2010 | US20100291138 Vaccine |
| 11/18/2010 | US20100291121 Tumour-Specific Animal Proteins |
| 11/18/2010 | US20100291119 Alpha B crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 11/18/2010 | US20100291065 Compositions for Protein Delivery and Methods of Use Thereof |
| 11/18/2010 | US20100291054 Novel regulatory t cells and uses thereof |
| 11/18/2010 | US20100291053 Inflammatory Disease Treatment |
| 11/18/2010 | US20100291052 Novel Microorganism Having Gastric-Juice Promoting Activity, and Its Secretory Product |
| 11/18/2010 | US20100291051 Agent for prevention of alcoholic hepatopathy |
| 11/18/2010 | US20100291050 Nutritional Compositions for Reducing Oxidative Damage |
| 11/18/2010 | US20100291049 Anti-wrinkle agent |
| 11/18/2010 | US20100291048 Modification of CXCR4 using engineered zinc finger proteins |
| 11/18/2010 | US20100291047 Use of Mesenchymal Stem Cells for Treating Genetic Disease and Disorders |
| 11/18/2010 | US20100291046 Equine Progenitor Cells |
| 11/18/2010 | US20100291045 Dynamic vibrational method and device for vocal fold tissue growth |
| 11/18/2010 | US20100291044 Lunasin-induced regulation of disease-related gene expression |
| 11/18/2010 | US20100291043 Il-12 immunotherapy for cancer |
| 11/18/2010 | US20100291042 Multipotent stem cells and uses thereof |
| 11/18/2010 | US20100291041 Bacteriophage preparation and use |
| 11/18/2010 | US20100291040 Virus-like particles for treatment of viral infections |